SCHEMBL3982009

SCHEMBL3982009

COc1ccc(C(=O)O)cc1NC(=O)OC(C)(C)C

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PPARG P37231 1/20 0.55
PPARA Q07869 1/20 0.55
NR1H4 Q96RI1 1/20 0.55
MAPK1 P28482 2/20 0.54
GAA P10253 2/20 0.54
LTB4R Q15722 6/20 0.53
CA12 O43570 1/20 0.53
CA1 P00915 1/20 0.53
CA2 P00918 1/20 0.53
CA4 P22748 1/20 0.53
CA6 P23280 1/20 0.53
CA7 P43166 1/20 0.53
TPMT P51580 1/20 0.53
CA9 Q16790 1/20 0.53
CA14 Q9ULX7 1/20 0.53
MEN1 O00255 1/20 0.50
POLB P06746 1/20 0.50
KMT2A Q03164 1/20 0.50
HDAC1 Q13547 1/20 0.49
HDAC8 Q9BY41 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30362191 1.00 PPARG (0.55) PPARGPPARANR1H4MAPK1GAA
SCHEMBL113522 0.89 CA12 (0.53) MAPK1CA12CA1CA2CA4
SCHEMBL3601292 0.89 KDM4E (0.52) GAAMEN1POLBKMT2AHDAC1
SCHEMBL16115115 0.86 TSHR (0.55) PPARGPPARANR1H4MAPK1GAA
SCHEMBL3256083 0.85 NPC1 (0.54) MAPK1MEN1POLBKMT2A
SCHEMBL3982928 0.85 HDAC1 (0.49) PPARGPPARANR1H4MAPK1GAA
SCHEMBL20053747 0.84 LTB4R (0.61) PPARGPPARANR1H4MAPK1GAA
SCHEMBL566467 0.83 CREBBP (0.60) GAALTB4RMEN1POLBKMT2A
SCHEMBL13345457 0.83 PPARG (0.40) PPARGPPARANR1H4MAPK1GAA
SCHEMBL2283371 0.82 PPARG (0.51) PPARGMAPK1GAAMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110698459-B 1-phenyl-2-pyridylalkyl alcohol derivatives as phosphodiesterase inhibitors 奇斯药制品公司 2023-05-05 CN disclosed
CN-110698459-A 1-phenyl-2-pyridylalkyl alcohol derivatives as phosphodiesterase inhibitors 奇斯药制品公司 2020-01-17 CN disclosed
EP-2928869-B1 1-PHENYL-2-PYRIDINYL ALKYL ALCOHOL DERIVATIVES AS PHOSPHODIESTERASE INHIBITORS CHIESI FARM SPA (IT) 2019-02-20 EP disclosed
US-9944612-B2 1-phenyl-2-pyridinyl alkyl alcohol derivatives as phosphodiesterase inhibitors CHIESI FARMACEUTICI S.P.A. (IT) 2018-04-17 US disclosed
US-9944612-B2 1-phenyl-2-pyridinyl alkyl alcohol derivatives as phosphodiesterase inhibitors CHIESI FARMACEUTICI S.P.A. (IT) 2018-04-17 US disclosed
US-9944612-B2 1-phenyl-2-pyridinyl alkyl alcohol derivatives as phosphodiesterase inhibitors CHIESI FARMACEUTICI S.P.A. (IT) 2018-04-17 US disclosed
CN-104817489-B A kind of heterocycle biphenyl aryl urea compounds with antitumor activity and its preparation method and application 西安交通大学 2017-06-27 CN disclosed
EP-2760838-B1 DERIVATIVES OF 1-PHENYL-2-PYRIDINYL ALKYL ALCOHOLS AS PHOSPHODIESTERASE INHIBITORS CHIESI FARM SPA (IT) 2017-05-10 EP disclosed
EP-2928869-A1 1-PHENYL-2-PYRIDINYL ALKYL ALCOHOL DERIVATIVES AS PHOSPHODIESTERASE INHIBITORS Chiesi Farmaceutici S.p.A. (IT) 2015-10-14 EP disclosed
CN-104822659-A 1-Phenyl-2-pyridylalkyl alcohol derivatives as phosphodiesterase inhibitors CHIESI FARMA SPA 2015-08-05 CN disclosed
US-20140155391-A1 1-PHENYL-2-PYRIDINYL ALKYL ALCOHOL DERIVATIVES AS PHOSPHODIESTERASE INHIBITORS CHIESI FARMACEUTICI S.P.A. (IT) 2014-06-05 US disclosed
US-20140155391-A1 1-PHENYL-2-PYRIDINYL ALKYL ALCOHOL DERIVATIVES AS PHOSPHODIESTERASE INHIBITORS CHIESI FARMACEUTICI S.P.A. (IT) 2014-06-05 US disclosed
US-20140155391-A1 1-PHENYL-2-PYRIDINYL ALKYL ALCOHOL DERIVATIVES AS PHOSPHODIESTERASE INHIBITORS CHIESI FARMACEUTICI S.P.A. (IT) 2014-06-05 US disclosed
CN-100543022-C 2-furancarboxylic acid hydrazide compound and contain the pharmaceutical composition of this compound DAINIPPON PHARMACEUTICAL CO (JP) 2009-09-23 CN disclosed
US-7514452-B2 2-furancarboxylic acid hydrazides and pharmaceutical compositions containing the same DAINIPPON PHARMACEUTICAL CO., LTD (JP) 2009-04-07 US disclosed
US-7129208-B2 Synthetic ion channels WASHINGTON UNIVERSITY (US) 2006-10-31 US disclosed
US-20050171196-A1 2-Furancarboxylic acid hydrazides and pharmaceutical compositions containing the same DAINIPPON SUMITOMO PHARMA CO., LTD. (JP) 2005-08-04 US disclosed
CN-1628111-A 2-furancarboxylic acid hydrazides and pharmaceutical compositions containing the same DAINIPPON PHARMACEUTICAL CO (JP) 2005-06-15 CN disclosed
EP-1489077-A1 2-FURANCARBOXYLIC ACID HYDRAZIDES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME DAINIPPON PHARMACEUTICAL CO., LTD. (JP) 2004-12-22 EP disclosed
US-20030176641-A1 Synthetic ion channels WASHINGTON UNIVERSITY 2003-09-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140155391-A1 1-PHENYL-2-PYRIDINYL ALKYL ALCOHOL DERIVATIVES AS PHOSPHODIESTERASE INHIBITORS PDE4A, PDE4B, PDE3A PPARG 1595/4885PPARA 1389/4885NR1H4 1738/4885
US-20050171196-A1 2-Furancarboxylic acid hydrazides and pharmaceutical compositions containing the same GLP1R, GCGR, GPR119 PPARG 155/4885PPARA 226/4885NR1H4 288/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.